Oncology PracticeThe march of immunotherapy continues at ESMO 2020September 15, 2020ImmunotherapyGenitourinary CancerGastroenterologyLung CancerPatient & Survivor CareRenal Cell CarcinomaPractice Management
Oncology PracticeImmunotherapy should not be withheld because of sex, age, or PSAugust 27, 2020ImmunotherapyLung CancerMelanomaPatient & Survivor CareBreast CancerGastroenterologyGenitourinary Cancer
Oncology PracticeFDA approves new indications for pembrolizumabJuly 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticePersonalized cancer vaccine may enhance checkpoint inhibitor activityJune 25, 2020ImmunotherapyBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMelanoma
Oncology PracticeNew registry focuses on rheumatic immune-related AEs of cancer therapyJune 18, 2020Immunotherapy
Oncology PracticeFDA approves immunotherapy combo for liver cancerMarch 11, 2020GastroenterologyImmunotherapyGastrointestinal Cancer
Oncology PracticeTumor neoantigenicity metric improves prediction of response to immunotherapyFebruary 22, 2020ImmunotherapyLung CancerRenal Cell CarcinomaMelanoma
Hematology NewsExperts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020B Cell LymphomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell DisordersMantle Cell Lymphoma
Oncology PracticeNew toxicity subscale measures QOL in cancer patients on checkpoint inhibitorsJanuary 11, 2020ImmunotherapyLung CancerMelanomaCellular Therapy
Hematology NewsCAR T cells produce complete responses in T-cell malignanciesJanuary 7, 2020ALLT Cell LymphomasCellular TherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncology
Hematology NewsCAR T-cell therapy advances in CLLDecember 26, 2019CLLCellular TherapyB Cell LymphomaLeukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
Hematology NewsInhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patientsDecember 23, 2019Multiple MyelomaImmunotherapyLymphoma & Plasma Cell DisordersCellular TherapyImmuno-oncology
Hematology NewsSurvival data reported from largest CAR T trial in B-cell lymphomaDecember 20, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersDLBCLFollicular LymphomaIndolent LymphomaImmuno-oncologyImmunotherapy
Hematology News‘Real-world’ data show CAR T therapies are cost effectiveDecember 13, 2019Business of MedicineCellular TherapyImmuno-oncologyImmunotherapyPractice Management
